2-(4-iodo-2,5-dimetoxifenil)-N-[(2-metoxifenil)metil]etamina ou 25I-NBOMe: caracterização química de uma designer drug
dc.creator | Santos, Pâmella Ferraz dos | |
dc.creator | Souza, Lindamara Maria de | |
dc.creator | Merlo, Bianca Bortolini | |
dc.creator | Costa, Helber Barcellos da | |
dc.creator | Tose, Lilian Valadares | |
dc.creator | Santos, Heloa | |
dc.creator | Costa, Gabriela Vanini | |
dc.creator | Machado, Leandro Fernandes | |
dc.creator | Ortiz, Rafael Scorsatto | |
dc.creator | Limberger, Renata Pereira | |
dc.creator | Vaz, Boniek Gontijo | |
dc.creator | Romão, Wanderson | |
dc.date.accessioned | 2023-07-03T15:27:13Z | |
dc.date.available | 2023-07-03T15:27:13Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5- dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe was explored using thin layer chromatography (TLC), ultraviolet-visible spectrophotometry (UV-Vis), attenuated total reflection with Fourier transform infrared spectroscopy(ATRFTIR), gas chromatography mass spectrometry (GC-MS) and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FT-ICR MS). First, the TLC technique was effective for identifying spots related to 25C-, 25B- and 25I-NBOMe compounds, all with the same retention factor, Rf ≈ 0.50. No spot was detected for 2,5-dimethoxy-4-bromoamphetamine, 2,5-Dimethoxy-4-chloroamphetamine or lysergic acid diethylamide compounds. ATR-FTIR preserved the physical-chemical properties of the material, whereas GC-MS and ESI-MS showed better analytical selectivity. ESI(+)FT-ICR MS was used to identify the exact mass (m/z 428.1706 for the [M + H]+ ion), molecular formula (M = C18H22INO3), degree of unsaturation (DBE = 8) and the chemical structure (from collision induced dissociation, CID, experiments) of the 25I-NBOMe compound. Furthermore, the ATR-FTIR and CID results suggested the presence of isomers, where a second structure is proposed as an isomer of the 25I-NBOMe molecule. | pt_BR |
dc.identifier.citation | SANTOS, Pâmella F. dos et al. 2-(4-iodo-2,5-dimetoxifenil)-N-[(2-metoxifenil)metil]etamina ou 25I-NBOMe: caracterização química de uma designer drug. Química Nova, São Paulo, v. 39, n. 2, p. 229-237, 2016. DOI: 10.5935/0100-4042.20150178. Disponível em: https://quimicanova.sbq.org.br/detalhe_artigo.asp?id=6352. Acesso em: 21 jun. 2023. | pt_BR |
dc.identifier.doi | 10.5935/0100-4042.20150178 | |
dc.identifier.issn | e- 1678-7064 | |
dc.identifier.issn | 0100-4042 | |
dc.identifier.uri | http://repositorio.bc.ufg.br/handle/ri/22871 | |
dc.language.iso | por | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | Instituto de Química - IQ (RMG) | pt_BR |
dc.rights | Acesso Aberto | pt_BR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Designer drugs | pt_BR |
dc.subject | 25I-NBOMe | pt_BR |
dc.subject | CCD | pt_BR |
dc.subject | ATR-FTIR | pt_BR |
dc.subject | GC-MS | pt_BR |
dc.subject | ESI(+)-FT-ICR MS | pt_BR |
dc.title | 2-(4-iodo-2,5-dimetoxifenil)-N-[(2-metoxifenil)metil]etamina ou 25I-NBOMe: caracterização química de uma designer drug | pt_BR |
dc.title.alternative | 2-(4-iodine-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe: chemical chracterization of a designer drug | pt_BR |
dc.type | Artigo | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- Artigo - Pâmella Ferraz dos Santos - 2016.pdf
- Tamanho:
- 1.33 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: